3B

3billion Inc.

AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.

394800 | KO

Overview

Corporate Details

ISIN(s):
KR7394800007
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로 415 8층(삼성동, 엘7호텔스강남타워), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

3billion Inc. is a biotechnology company specializing in AI-driven genetic diagnostics for rare diseases. The company aims to end the "diagnostic odyssey" for patients by providing fast, accurate, and comprehensive testing solutions. Leveraging its artificial intelligence platform, 3billion analyzes over 20,000 genes through services like whole-exome (3B-EXOME) and whole-genome sequencing. A key differentiator is its commitment to unlimited reanalysis, which re-evaluates patient data against new scientific discoveries to increase diagnostic yield over time. 3billion collaborates with a global network of over 700 institutions and 1,600 healthcare providers across more than 70 countries to make its one-stop diagnostic services accessible to patients with suspected rare diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 26.0 KB
2025-09-01 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-29 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 9.8 KB
2025-08-29 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 875.0 KB
2025-07-02 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.8 KB
2025-07-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 69.7 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 647.6 KB
2025-04-17 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.5 KB
2025-03-31 00:00
Remuneration Information
주식매수선택권부여에관한신고
Korean 14.6 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 19.1 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 367.7 KB

Automate Your Workflow. Get a real-time feed of all 3billion Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 3billion Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 3billion Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.